Advertisement
Screener

NU SKIN ENTERPRISES, INC. (NUS) Overview

NU SKIN ENTERPRISES, INC. (NUS) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -5.14; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 0.04; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual 0.34; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual 0.43; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$3.89$4.88$6.14$7.72$9.70$12.192025-11-062026-11-06$3.89$6.70$11.54$19.89$34.27$59.062021-11-082026-11-06$3.89$7.35$13.90$26.29$49.71$94.022016-11-072026-11-06$3.89$8.28$17.66$37.64$80.25$171.072006-11-062026-11-06$3.89$8.49$18.54$40.50$88.46$193.241996-11-222026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$4.09
Previous close
$4.59
Change
-$0.50
Change (%)
-10.89%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

NUS
-50.86%
S&P 500
(m)

1 year

NUS
-60.63%
S&P 500
(m)

3 years

NUS
-76.03%
S&P 500
(m)

5 years

NUS
-86.48%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -5.14

-5.22-3.33-1.450.442.3231 Mar 2025: estimate (m); actual 2.1431 Mar 2025(m)30 Jun 2025: estimate (m); actual 0.4330 Jun 2025(m)30 Sept 2025: estimate (m); actual 0.3430 Sept 2025(m)31 Mar 2026: estimate (m); actual 0.0431 Mar 2026(m)30 Jun 2026: estimate (m); actual -5.1430 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-5.14(m)(m)
1 Jan 202631 Mar 2026(m)0.04(m)(m)
1 Jul 202530 Sept 2025(m)0.34(m)(m)
1 Apr 202530 Jun 2025(m)0.43(m)(m)
1 Jan 202531 Mar 2025(m)2.14(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual 3.18

-3.03-1.430.171.763.3631 Dec 2021: estimate (m); actual 2.8631 Dec 2021(m)31 Dec 2022: estimate (m); actual 2.0731 Dec 2022(m)31 Dec 2023: estimate (m); actual 0.1731 Dec 2023(m)31 Dec 2024: estimate (m); actual -2.9531 Dec 2024(m)31 Dec 2025: estimate (m); actual 3.1831 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)3.18(m)(m)
1 Jan 202431 Dec 2024(m)-2.95(m)(m)
1 Jan 202331 Dec 2023(m)0.17(m)(m)
1 Jan 202231 Dec 2022(m)2.07(m)(m)
1 Jan 202131 Dec 2021(m)2.86(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 320.11M ■ Earnings -249.80M — Profit margin -78.03%

-324.21M-79.0%-67.90M-50.8%188.42M-22.6%444.73M5.7%30 Sept 2025: revenue 364.21M; earnings 17.08M; profit margin 4.69%30 Sept 202531 Dec 2025: revenue 370.32M*; earnings 14.49M*; profit margin 3.91%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 320.61M; earnings 1.84M; profit margin 0.57%31 Mar 202630 Jun 2026: revenue 320.11M; earnings -249.80M; profit margin -78.03%30 Jun 2026

31 Dec 2025 ■ Revenue 1.49B ■ Earnings 0.16B — Profit margin 10.79%

-0.43B-9.5%0.55B-2.4%1.53B4.7%2.51B11.8%31 Dec 2022: revenue 2.23B; earnings 0.10B; profit margin 4.71%31 Dec 202231 Dec 2023: revenue 1.97B; earnings 0.01B; profit margin 0.44%31 Dec 202331 Dec 2024: revenue 1.73B; earnings -0.15B; profit margin -8.46%31 Dec 202431 Dec 2025: revenue 1.49B; earnings 0.16B; profit margin 10.79%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$4.09(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$4.09High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning NUS

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending (m).

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
(m)
Profit margin
(m)
Return on assets · 12 month
(m)
Stock compensation expense · all employees · 12 months
(m)
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
532.61K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-5.56%*
Total return · month
-5.36%*
Total return · quarter
-11.77%*
Total return · half year
-34.18%*
Total return · year to date
-50.86%*
Total return · 1 year
-60.63%*
Total return · 3 years
-76.03%*
Total return · 5 years
-86.48%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
(m)
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

NU SKIN ENTERPRISES, INC. Overview

View more →

(m)

(m)

SEC CIK
1021561
Industry (SIC)
5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
Country of operation
United States
Business address
75 WEST CENTER ST, ATTN: GREGORY BELLISTON, PROVO, Utah, 84601, United States
Fiscal year end
1231
Phone
801-345-1000

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cosmos Health Inc. (COSM)Greece$0.038B-0.60
HWH International Inc. (HWH)United States$0.021B-4.08
DataMeds AI, Inc. (MEDS)United States$0.011B
HERBALIFE LTD. (HLF)$1.281B8.39
CARDINAL HEALTH INC (CAH)United States$51.753B29.38
Cencora, Inc. (COR)United States$59.130B20.57
MCKESSON CORP (MCK)United States$101.317B19.78